According to sources, it has been revealed that soon the patients suffering from heart problems will be assisted with vaccination to prevent heart attacks.
It has been unveiled that such a vaccination will be delivered either via an injection or nasal spray and is expected to be introduced in the market in a time period of five years.
The scientists, who discovered this drug, stated that while they designed the drug, they laid more emphasis on the major cause due to which people suffer from heart attacks. This is supposed to be the first time that such a drug has been designed, as the current treatments emphasize on reducing the cholesterol level and blood pressure.
The scientists affirmed that the drug will act in a way which will help in the production of antibodies that will further; prevent the building up of fat in the arteries, the main reason due to which heart attack cases are encountered. Now, when the fat deposits in the arteries, they become narrow, due to which the heart has to exert more to pump blood.
The tests carried out by researchers at the Lund University in Sweden affirmed that the drug is capable of cutting down the rate of fat build up in the arteries by 70% in mice.
However, the scientists are yet to be permitted by the regulatory authorities to carry out clinical trials on 144 heart disease sufferers in the US and Canada.
The drug has been able to provide with positive results till now. However, the scientists are still discovering different ways in which the drug can be administered. Moreover, it is being expected that the drug will be licensed within five years.
However, the scientists have asserted that the treatment to show its effectiveness may take long time. Moreover, it will be majorly used for only those who are at a higher risk, as it the treatment will be very expensive.
- Google Nexus 10 2 launch date reportedly delayed to 2014
- Ford unveils new 2015 Mustang in its first global launch
- Ford set to unveil its all-new 2015 Mustang --- the first Mustang to be sold globally
- Finnish startup Jolla Oy launches its self-titled Jolla headset in Europe
- HTC to launch dual-SIM variant of flagship HTC One handset in UK